Michele Bottosso

831 total citations
34 papers, 504 citations indexed

About

Michele Bottosso is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Michele Bottosso has authored 34 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 16 papers in Cancer Research. Recurrent topics in Michele Bottosso's work include Advanced Breast Cancer Therapies (13 papers), Breast Cancer Treatment Studies (13 papers) and HER2/EGFR in Cancer Research (13 papers). Michele Bottosso is often cited by papers focused on Advanced Breast Cancer Therapies (13 papers), Breast Cancer Treatment Studies (13 papers) and HER2/EGFR in Cancer Research (13 papers). Michele Bottosso collaborates with scholars based in Italy, France and United States. Michele Bottosso's co-authors include Valentina Guarneri, Maria Vittoria Dieci, Gaia Griguolo, Federica Miglietta, Grazia Maria Vernaci, Pierfranco Conté, Marcello Mele, Elisa Genovesi, Tommaso Giarratano and Matteo Fassan and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

Michele Bottosso

26 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michele Bottosso Italy	11	367	237	160	148	67	34	504
J-Y Pierga France	11	376 1.0×	183 0.8×	135 0.8×	67 0.5×	113 1.7×	53	479
Yoshikane Nonagase Japan	11	390 1.1×	103 0.4×	204 1.3×	185 1.3×	125 1.9×	19	515
Willemijne A.M.E. Schrijver Netherlands	11	286 0.8×	205 0.9×	167 1.0×	65 0.4×	135 2.0×	13	470
Mary-Ann Lindsay United States	5	487 1.3×	182 0.8×	151 0.9×	203 1.4×	162 2.4×	5	588
M. Byakhov Spain	4	376 1.0×	240 1.0×	66 0.4×	136 0.9×	53 0.8×	6	451
Roberta Guzman United States	8	539 1.5×	248 1.0×	107 0.7×	289 2.0×	235 3.5×	11	684
Yoomi Choi South Korea	7	379 1.0×	286 1.2×	127 0.8×	172 1.2×	249 3.7×	8	626
Jennifer A. Lacap France	8	418 1.1×	96 0.4×	227 1.4×	149 1.0×	146 2.2×	12	558
Angela Santiago United States	7	516 1.4×	216 0.9×	115 0.7×	289 2.0×	230 3.4×	9	665
M. Pegram United States	6	453 1.2×	199 0.8×	82 0.5×	182 1.2×	177 2.6×	14	571

Countries citing papers authored by Michele Bottosso

Since Specialization

Citations

This map shows the geographic impact of Michele Bottosso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Bottosso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Bottosso more than expected).

Fields of papers citing papers by Michele Bottosso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Bottosso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Bottosso. The network helps show where Michele Bottosso may publish in the future.

Co-authorship network of co-authors of Michele Bottosso

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Bottosso. A scholar is included among the top collaborators of Michele Bottosso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Bottosso. Michele Bottosso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bottosso, Michele, Federica Miglietta, Daniele Generali, et al.. (2025). Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications. npj Breast Cancer. 12(1). 23–23.

Bottosso, Michele, Gaia Griguolo, Séverine Guiu, et al.. (2025). Temporal evolution of breast cancer brain metastases treatments and outcomes. npj Breast Cancer. 11(1). 20–20.

Giarratano, Tommaso, Cristina Falci, Federica Miglietta, et al.. (2025). Real-world outcomes of early-stage HER2-positive breast cancer patients treated with adjuvant paclitaxel and trastuzumab. npj Breast Cancer. 11(1). 132–132.

Griguolo, Gaia, Michele Bottosso, A Crema, et al.. (2025). Exceptional responses to systemic treatment in metastatic breast cancer: clinical features and long-term outcomes. European Journal of Cancer. 219. 115321–115321. 2 indexed citations

Griguolo, Gaia, Maria Vittoria Dieci, Susan Fineberg, et al.. (2025). Gene expression profiling in a retrospective real-world cohort of breast cancer brain metastases and paired primary tumors identifies biological changes with potential therapeutic implications. ESMO Open. 10(8). 105507–105507.

Ferro, Alessandra, Michele Bottosso, Maria Vittoria Dieci, et al.. (2024). Clinical applications of radiomics and deep learning in breast and lung cancer: A narrative literature review on current evidence and future perspectives. Critical Reviews in Oncology/Hematology. 203. 104479–104479. 8 indexed citations

Bottosso, Michele, Fernanda Mosele, Stefan Michiels, et al.. (2024). Moving toward precision medicine to predict drug sensitivity in patients with metastatic breast cancer. ESMO Open. 9(3). 102247–102247. 12 indexed citations

Sandoval, Renata Lazari, Michele Bottosso, Tianyu Li, et al.. (2024). TP53-associated early breast cancer: new observations from a large cohort. JNCI Journal of the National Cancer Institute. 116(8). 1246–1254. 6 indexed citations

Bottosso, Michele, Benjamin Verret, Olivier Caron, et al.. (2024). Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome. JCO Precision Oncology. 8(8). e2400139–e2400139. 3 indexed citations

10.

Bottosso, Michele, Federica Miglietta, Grazia Maria Vernaci, et al.. (2024). Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2− Breast Cancer. Clinical Cancer Research. 30(14). 2884–2894. 3 indexed citations

11.

Griguolo, Gaia, Laia Paré, Federica Miglietta, et al.. (2024). Association of tumor-infiltrating lymphocytes (TILs) and immune signatures with PAM50 intrinsic subtyping hormone receptor-positive (HR+)/HER2-negative (HER2-) early breast cancer (BC): A translational analysis of two multicentric neoadjuvant trials.. Journal of Clinical Oncology. 42(16_suppl). 558–558.

12.

Bottosso, Michele, Gaia Griguolo, Federica Miglietta, et al.. (2023). Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases. British Journal of Cancer. 128(7). 1286–1293. 5 indexed citations

13.

Griguolo, Gaia, Michele Bottosso, Francesca Caumo, et al.. (2023). Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients. International Journal of Cancer. 153(6). 1217–1226.

14.

Griguolo, Gaia, Anna Tosi, Maria Vittoria Dieci, et al.. (2022). A comprehensive profiling of the immune microenvironment of breast cancer brain metastases. Neuro-Oncology. 24(12). 2146–2158. 24 indexed citations

15.

Guarneri, Valentina, Fara Brasó‐Maristany, Maria Vittoria Dieci, et al.. (2022). HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial. EBioMedicine. 85. 104320–104320. 21 indexed citations

16.

Miglietta, Federica, Gaia Griguolo, Michele Bottosso, et al.. (2022). HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment. npj Breast Cancer. 8(1). 66–66. 75 indexed citations

17.

Dieci, Maria Vittoria, Gaia Griguolo, Federica Miglietta, et al.. (2022). 140MO HER2DX genomic test in HER2-positive/hormone receptor-positive (HER2+/HR+) breast cancer (BC) treated with neoadjuvant trastuzumab (T) and pertuzumab (P): A correlative analysis from the PerELISA trial. Annals of Oncology. 33. S603–S603. 1 indexed citations

18.

Miglietta, Federica, Gaia Griguolo, Michele Bottosso, et al.. (2021). Evolution of HER2-low expression from primary to recurrent breast cancer. npj Breast Cancer. 7(1). 137–137. 150 indexed citations

19.

Miglietta, Federica, Gaia Griguolo, Michele Bottosso, et al.. (2021). 4MO_PR HER2-low breast cancer: Evolution from primary breast cancer to relapse. Annals of Oncology. 32. S23–S23. 1 indexed citations

20.

Miglietta, Federica, Maria Vittoria Dieci, Vassilena Tsvetkova, et al.. (2020). Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer. The Oncologist. 25(9). e1355–e1362. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact